Literature DB >> 23599511

III. Aprotinin and cardiac surgery: a sorry tale of evidence misused.

V McMullan, R P Alston.   

Abstract

Mesh:

Substances:

Year:  2013        PMID: 23599511     DOI: 10.1093/bja/aet008

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


× No keyword cloud information.
  7 in total

1.  Aprotinin, but not ε-aminocaproic acid and tranexamic acid, exerts neuroprotection against excitotoxic injury in an in vitro neuronal cell culture model.

Authors:  Zhaohui Lu; Ludmila Korotcova; Akira Murata; Nobuyuki Ishibashi; Richard A Jonas
Journal:  J Thorac Cardiovasc Surg       Date:  2013-11-13       Impact factor: 5.209

2.  Updates on coagulation management in cardiac surgery.

Authors:  Mahdi Najafi; David Faraoni
Journal:  J Tehran Heart Cent       Date:  2014

3.  Issues in assessing products for the treatment of hemophilia - the intersection between efficacy, economics, and ethics.

Authors:  Albert Farrugia; Declan Noone; Uwe Schlenkrich; Steffen Schlenkrich; Brian O'Mahony; Josephine Cassar
Journal:  J Blood Med       Date:  2015-06-15

Review 4.  Bleeding related to disturbed fibrinolysis.

Authors:  Krasimir Kolev; Colin Longstaff
Journal:  Br J Haematol       Date:  2016-08-01       Impact factor: 6.998

5.  Novel hemostatic biomolecules based on elastin-like polypeptides and the self-assembling peptide RADA-16.

Authors:  Shasha Yang; Sili Wei; Yun Mao; Hanxue Zheng; Juantao Feng; Jihong Cui; Xin Xie; Fulin Chen; Honmgmin Li
Journal:  BMC Biotechnol       Date:  2018-03-07       Impact factor: 2.563

Review 6.  Cardiac Surgery and Blood-Saving Techniques: An Update.

Authors:  Muhammad Saad Yousuf; Khalid Samad; Syed Shabbir Ahmed; Khalid M Siddiqui; Hameed Ullah
Journal:  Cureus       Date:  2022-01-13

7.  Use and safety of aprotinin in routine clinical practice: A European postauthorisation safety study conducted in patients undergoing cardiac surgery.

Authors:  Stefan De Hert; Alexandre Ouattara; David Royston; Jan van der Linden; Kai Zacharowski
Journal:  Eur J Anaesthesiol       Date:  2022-06-29       Impact factor: 4.183

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.